100 Most Popular
You can buy or sell Tilray and other stocks, options, ETFs, and crypto commission-free!
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. Read More The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
Nanaimo, British Columbia
52 Week High
52 Week Low
100 Most Popular
Don't Laugh: Aurora Cannabis, Canopy Growth, and Tilray Could Be Big-Time Bargains
Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), and Tilray (NASDAQ: TLRY) combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion.
The Motley FoolMar 23
The Most Compelling Argument Why Tilray Is a Better Buy Than Aurora Cannabis and Canopy Growth
Let me first state unequivocally that I have in no way been a big fan of Tilray (NASDAQ:TLRY). Last November, I called Tilray the most dangerous big marijuana stock on the market.
Seeking AlphaMar 23
What Tilray Thinks About The 'Farming Business' And Why The Company May Need To Raise More Capital Soon
Privateer has said it does not plan to sell shares in 1H 2019. What about 2H? The company may need to raise additional cash, likely through an equity offering, in the near term. Management distanced itself from the "farming business" and said that Canadian "supply assets" were "overpriced" Although many companies are starting to gear up to release financial results for the first quarter, investors have nevertheless waited patiently for Tilray (TLRY) to release its results for the fourth quarter of 2018 t...
-$0.12 per share
-$0.33 per share